Murata, S., Nakamura, M., Sugihara, K., Sakai, T., Ishioka, K., Takahashi, S., Sasada, S., Yasuda, H., & Fukunaga, K. (2022). The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma. Asian Pacific Journal of Cancer Care, 7(1), 191-196.